Early hormonal data from a multicentre phase II trial using transdermal oestrogen patches as first-line hormonal therapy in patients with locally advanced or metastatic prostate cancer

OBJECTIVE: To assess the hormonal effects of Fem7® (Merck, KGaA, Darmstadt, Germany) 100 μg transdermal oestrogen patches on men undergoing first-line androgen-deprivation therapy for prostate cancer. PATIENTS AND METHODS: PATCH is a multicentre, randomized, phase II trial for men with locally advan...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Langley, Ruth E., Godsland, Ian F., Kynaston, Howard, Clarke, Noel W., Rosen, Stuart D., Morgan, Rachel C., Pollock, Philip, Kockelbergh, Roger, Lalani, El-Nasir, Dearnaley, David, Parmar, Mahesh, Abel, Paul D.
Format: Artigo
Langue:Inglês
Publié: 2008
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2564109/
https://ncbi.nlm.nih.gov/pubmed/18422771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1464-410X.2008.07583.x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires